Next Science Limited (NXS.AX)
AUD 0.1
(-1.0%)
AUD 0.1
(-1.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 47.22 Million USD | 55.29% |
| 2022 | 30.21 Million USD | 43.94% |
| 2021 | 20.99 Million AUD | -1.99% |
| 2020 | 21.42 Million AUD | 96.56% |
| 2019 | 10.89 Million AUD | 43.66% |
| 2018 | 7.58 Million AUD | 16289.4% |
| 2017 | 46.28 Thousand AUD | -98.25% |
| 2016 | 2.64 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 22.23 Million AUD | -14.33% |
| 2023 FY | 46.92 Million USD | 55.29% |
| 2023 Q2 | 21.56 Million AUD | 40.17% |
| 2023 Q4 | 25.41 Million AUD | 17.86% |
| 2022 Q2 | 14.8 Million AUD | 17.89% |
| 2022 FY | 30.21 Million USD | 43.94% |
| 2022 Q4 | 15.38 Million AUD | 3.87% |
| 2021 FY | 20.99 Million AUD | -1.99% |
| 2021 Q2 | 9.53 Million AUD | -4.94% |
| 2021 Q4 | 12.56 Million AUD | 31.7% |
| 2020 FY | 21.42 Million AUD | 96.56% |
| 2020 Q2 | 5.3 Million AUD | 10.56% |
| 2020 Q4 | 10.03 Million AUD | 89.15% |
| 2019 Q4 | 4.79 Million AUD | -21.01% |
| 2019 FY | 10.89 Million AUD | 43.66% |
| 2019 Q2 | 6.07 Million AUD | 573.14% |
| 2018 FY | 7.58 Million AUD | 16289.4% |
| 2018 Q4 | 902.37 Thousand AUD | 0.0% |
| 2017 FY | 46.28 Thousand AUD | -98.25% |
| 2016 FY | 2.64 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Althea Group Holdings Limited | 17.46 Million AUD | -170.426% |
| Cann Group Limited | 15.37 Million AUD | -207.209% |
| ECS Botanics Holdings Ltd | 6.07 Million AUD | -677.557% |
| Ecofibre Limited | 24.94 Million AUD | -89.303% |
| Elixinol Wellness Limited | 3.42 Million AUD | -1280.912% |
| Hygrovest Limited | 260 Thousand AUD | -18064.309% |
| IDT Australia Limited | 12.44 Million AUD | -279.518% |
| Invion Limited | 8.55 Million AUD | -452.013% |
| Little Green Pharma Ltd | 25.38 Million AUD | -86.042% |
| Live Verdure Ltd | 13.23 Million AUD | -256.805% |
| Medical Developments International Limited | 24.36 Million AUD | -93.824% |
| Vitura Health Limited | 29.35 Million AUD | -60.896% |
| Vita Life Sciences Limited | 30.38 Million AUD | -55.409% |